Biomerica Inc (BMRA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Biomerica Inc (BMRA) has a cash flow conversion efficiency ratio of -0.377x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.25 Million) by net assets ($3.32 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Biomerica Inc (BMRA) liquidity interval to measure how many days the company can operate on defensive assets alone.
Biomerica Inc - Cash Flow Conversion Efficiency Trend (1989–2025)
This chart illustrates how Biomerica Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Biomerica Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Biomerica Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nexcom AS
CO:NEXCOM
|
0.754x |
|
INC S.A.
WAR:INC
|
-0.047x |
|
Lianhua Supermarket Holdings Co. Ltd
F:LSJ
|
2.019x |
|
Auction Technology Group PLC
LSE:ATG
|
0.068x |
|
RUBIX Resources Ltd
AU:RB6
|
-1.211x |
|
Sonoro Energy Ltd
V:SNV
|
-0.347x |
|
Itech Minerals Ltd
AU:ITM
|
-0.014x |
|
GACM Technologies Limited
NSE:GATECH
|
N/A |
Annual Cash Flow Conversion Efficiency for Biomerica Inc (1989–2025)
The table below shows the annual cash flow conversion efficiency of Biomerica Inc from 1989 to 2025. For the full company profile with market capitalisation and key ratios, see BMRA market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | $4.11 Million | $-3.84 Million | -0.936x | -15.04% |
| 2024-05-31 | $6.59 Million | $-5.36 Million | -0.813x | -74.21% |
| 2023-05-31 | $11.72 Million | $-5.47 Million | -0.467x | -708.86% |
| 2022-05-31 | $8.32 Million | $-480.53K | -0.058x | +89.86% |
| 2021-05-31 | $9.23 Million | $-5.25 Million | -0.569x | -88.24% |
| 2020-05-31 | $14.21 Million | $-4.30 Million | -0.302x | +46.36% |
| 2019-05-31 | $3.98 Million | $-2.24 Million | -0.564x | -107.66% |
| 2018-05-31 | $4.33 Million | $-1.17 Million | -0.271x | -68.57% |
| 2017-05-31 | $4.49 Million | $-722.86K | -0.161x | -302.63% |
| 2016-05-31 | $5.22 Million | $-208.78K | -0.040x | +44.76% |
| 2015-05-31 | $5.60 Million | $-405.48K | -0.072x | +50.34% |
| 2014-05-31 | $5.91 Million | $-862.27K | -0.146x | -161.02% |
| 2013-05-31 | $5.83 Million | $1.39 Million | 0.239x | +706.88% |
| 2012-05-31 | $4.98 Million | $147.41K | 0.030x | -61.00% |
| 2011-05-31 | $4.33 Million | $328.80K | 0.076x | +230.18% |
| 2010-05-31 | $4.06 Million | $-236.98K | -0.058x | -148.64% |
| 2009-05-31 | $4.35 Million | $-102.00K | -0.023x | +53.18% |
| 2008-05-31 | $3.88 Million | $-194.59K | -0.050x | -118.94% |
| 2007-05-31 | $1.75 Million | $463.71K | 0.265x | +173.07% |
| 2006-05-31 | $1.06 Million | $-385.17K | -0.362x | -1854.28% |
| 2005-05-31 | $3.53 Million | $72.92K | 0.021x | +196.65% |
| 2004-05-31 | $3.51 Million | $-75.03K | -0.021x | -113.52% |
| 2003-05-31 | $3.25 Million | $512.54K | 0.158x | +497.02% |
| 2002-05-31 | $3.30 Million | $-131.07K | -0.040x | -228.48% |
| 2001-05-31 | $3.52 Million | $108.95K | 0.031x | +105.93% |
| 2000-05-31 | $4.91 Million | $-2.56 Million | -0.522x | -709.72% |
| 1999-05-31 | $6.20 Million | $-400.00K | -0.065x | -200.00% |
| 1998-05-31 | $6.20 Million | $400.00K | 0.065x | -45.62% |
| 1997-05-31 | $5.90 Million | $700.00K | 0.119x | -2.71% |
| 1996-05-31 | $4.10 Million | $500.00K | 0.122x | -21.95% |
| 1995-05-31 | $3.20 Million | $500.00K | 0.156x | -48.44% |
| 1994-05-31 | $3.30 Million | $1.00 Million | 0.303x | +312.12% |
| 1993-05-31 | $2.80 Million | $-400.00K | -0.143x | +17.86% |
| 1992-05-31 | $2.30 Million | $-400.00K | -0.174x | -139.53% |
| 1991-05-31 | $2.50 Million | $1.10 Million | 0.440x | +1112.00% |
| 1990-05-31 | $4.60 Million | $-200.00K | -0.043x | +76.09% |
| 1989-05-31 | $3.30 Million | $-600.00K | -0.182x | -- |
About Biomerica Inc
Biomerica, Inc., a biomedical technology company, engages in developing, patenting, manufacturing, and marketing diagnostic and therapeutic products for the detection and treatment of medical conditions and diseases worldwide. The company's diagnostic test kits are used to analyze blood, urine, nasal or fecal specimens from patients in the diagnosis of various diseases, food intolerances, and oth… Read more